We are delighted to highlight the opportunity to join our exclusive webinar with Pharmaphorum, which will involve a prestigious panel of speakers, including representatives from the European Society for Medical Oncology (ESMO), global pharmaceutical business Janssen, alongside our own experts from Ashfield Meetings & Events.
The foundation of this debate focuses on the findings of our recent Science of Healthcare Congresses white paper which takes a deep dive into how healthcare professionals (HCPs) view their whole congress experience as part of their medical learning journey. Both Jean-Yves MD, PhD, Chief Medical Officer, ESMO and Dr. Eva Hofstädter-Thalmann PhD, Strategic Lead in Medical Education and External Scientific Relations Oncology, Janssen, will provide insightful contributions, leading discussions from their individual perspectives.
“Some key questions that we’ll address during the session are ‘What makes attending a congress such a valuable form of education for time-restricted HCPs?’ ‘How can Associations and the pharmaceutical industry continue to create effective scientific congresses?’, and ‘How to ensure the medical education provides value to attendees?’ says Ashfield Meetings & Events Head of HCP Engagement, Andrew Moore, who will also be participating on the panel alongside Ashfield’s Katie Koziol, Director of Client Services. Both Katie and Andrew played critical roles in the research and production of the white paper, so their expertise will prove invaluable to the discussion.
We’d like to invite you to join the webinar to further understand the importance physicians place on the whole congress experience as a key part of their medical learning journey.
Register today to make sure your future congresses are innovative and forward-thinking in their offering to physicians.